NIH Guide, Volume 26, Number 5, February 14, 1997


P.T. 34


  Biomedical Research, Multidiscipl 

  Clinical Medicine, General 

  Grants Administration/Policy+ 

  Drugs/Drug Abuse 


National Institute on Drug Abuse




This clarification to NIDA Supplemental Information  (published in

the NIH Guide, Vol. 24, No. 32, September 1, 1995) to the National

Institutes of Health (NIH) career development program announcements

(K Awards) is intended to provide additional information for

potential applicants on the unique aspects of National Institute on

Drug Abuse (NIDA) career development programs.  Two sections have

been added -- renewal of K02 and eligibility requirements of the K01.

The NIH program announcements addressed by this supplement are the



o  PA-95-049:  Mentored Research Scientist Development Award (K01) o

PA-95-050:  Independent Scientist Award (K02)

o  PA-95-051:  Senior Scientist Award (K05)

o  PA-95-053:  Mentored Clinical Scientist Development Award (K08) o

PA-95-054:  Mentored Clinical Scientists Development Program Award



The guidelines and procedures outlined in the NIH program

announcements must be followed closely when an application is being

prepared for submission to the NIDA.  Particular attention should be

paid to the purpose of each award mechanism, its eligibility

requirements, and its review considerations.  For example, the K12

program mechanism will accommodate the research career pathways of

clinicians in fields related to NIDA's research mission.  Under the

K12 award, support will be provided to eligible institutions to

develop or enhance research training opportunities for clinicians

selected by the institution, who are training for careers as

independent researchers in the drug abuse and addiction area of

biomedical and behavioral research.  The K12 mechanism is designed to

foster the development of advanced clinical research skills through

didactic training and the mentored research experience.  Potential

applicants should contact appropriate NIDA staff for further



Supplemental Information for NIDA Applicants


The RESEARCH OBJECTIVES section of each program announcement should

be followed carefully during the preparation of an application.  Note

especially that differences exist among various NIH Institutes

regarding allowable costs. The unique aspects of NIDA allowable

costs, specifically in the categories of salary (all Ks) and research

development support (K01, K08), are listed below.




The NIDA contribution to the Principal Investigator's salary is

geared to the institutional base salary as follows:


Institutional Base Salary               NIDA Contribution


o  Up to $45,000                        100% of institutional base o

$45,001 to $60,000                   $45,000

o  $60,001 and over                     75% of institutional base

salary, Up to $75,000


Research Development Support (K01, K08)


The NIDA allows for funds up to $50,000 per year for research related

costs outlined in each program announcement.


Renewals (K02)


The Independent Scientist Award (K02) is renewable one time only.


Eligibility Requirements (K01)


A candidate for the Mentored Research Scientist Development Award

(K01) may not concurrently apply for any other PHS award that

duplicates the provisions of this award nor have another application

pending award.




Consultation with NIDA staff is encouraged especially during the

planning phase of the application.  Below are the names of the NIDA

staff who can provide further information:


Timothy P. Condon, Ph.D.

Office of Science Policy and Communications

National Institute on Drug Abuse

5600 Fishers Lane, Room 10A-55

Rockville, MD  20857

Telephone:  (301) 443-6072

FAX:  (301) 443-6277

Email:  TC52X@NIH.GOV


Lucinda L. Miner, Ph.D.

Office of Science Policy and Communications

Telephone:  (301) 443-6071

Email:  CM171W@NIH.GOV


Charles W. Sharp, Ph.D.

Basic Research

Parklawn Building, Room 10A-31

Telephone:  (301) 443-lB87

FAX:  (301) 594-6043

Email:  CS107M@NIH.GOV


Arthur Horton, Ed.D.

Clinical and Services Research

Parklawn Building, Room 10A-30

Telephone:  (301) 443-4060

FAX:  (301) 443-2317

Email:  AH6lX@NIH.GOV


Ann Blanken

Epidemiology and Prevention Research

Parklawn Building, Room 9A-55

Telephone:  (301) 443-6S43

FAX:  (301) 443-9847

Email:  AB108V@NIH.GOV


Jamie Biswas, Ph.D.

Medications Development

Parklawn Building, Room llA-55

Telephone:  (301) 443-5280

(301) 443-2599

Email:  JB168R@NIH.GOV



Return to 1997 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.